Global Image-Based Cytometry In Cell Analysis Market Size is valued at USD 3.8 Bn in 2024 and is predicted to reach USD 9.7 Bn by the year 2034 at a 10.0% CAGR during the forecast period for 2025-2034.
Cytometry is the science of determining cell identities through numerical analysis. The cytometer can evaluate many different cell characteristics, such as their size, shape, DNA content, and progression through the cell cycle. The most conventional method of cytometry involves the use of images. Image cytometers are operated using optical microscopy by statically imaging many cells. Drug development laboratories increasingly use cell-based screening assays to comprehend the process's intricacies better.
The use of cell-based assays in drug development has also grown in prominence due to the proliferation of data made possible by recent developments in cell biology, bioinformatics, molecular biology, genomics, and proteomics. In addition, key players' increased focus on new product development and strategic collaborations was influenced favourably by other variables, such as the pharmacological targets and therapeutic leads, leading to the growth of the global image-based cytometry in the cell analysis market.
Companies involved in the image-based cytometry in cell analysis market can anticipate substantial development prospects and increased spending on cutting-edge technology. It drives expansion globally and is expected to boost market expansion in the coming years.
The image-based cytometry in the cell analysis market is segmented based on therapeutic area and end-users. Based on therapeutic area, oncology & immune oncology. By end user, the market is segmented into biotechnology & pharmaceutical companies, academia, the cosmetic industry, contract research organizations, and contract development & manufacturing organizations.
The biotechnology & pharmaceutical companies' image-based cytometry in the cell analysis category is expected to hold a significant global market share in 2022. It is attributed that image-based cytometry has advanced to the point that the pharmaceutical and biotech industries may use it to evaluate massive datasets and draw conclusions about drug development from highly complicated images of cells. Different biotech and pharmaceutical firms can benefit from combining image-based cytometry with other cutting-edge technologies like artificial intelligence and high-content imaging cytometry.
The oncology segment is projected to advance in the global image-based cytometry cell analysis market. The Image cytometers provide both quantitative and qualitative insights into the properties of cancer cells. They contribute to better patient care and outcomes in oncology by aiding in correct diagnosis, treatment monitoring, and research, especially in countries like the US, Germany, the UK, China, and India.
The North American image-based cytometry in cell analysis market is expected to report the highest market share in revenue shortly. It can be attributed to the developments in healthcare infrastructure, the rising popularity of genomic screening initiatives, the growing interest in cell-based diagnostics and the characterization of cells in both healthy and sick states. In addition, the presence of key market competitors and improvements in cell analysis technology fuel expansion in the region's industries. In addition, Asia Pacific is projected to grow rapidly in the global image-based cytometry in cell analysis market because there have been increasing numbers of organizations and scientists using image-based cytometry, better image-based cytometry in cell analysis equipment, and growing financial support from the business.
|
Report Attribute |
Specifications |
|
Market Size Value In 2024 |
USD 3.8 Bn |
|
Revenue Forecast In 2034 |
USD 9.7 Bn |
|
Growth Rate CAGR |
CAGR of 10.0% from 2025 to 2034 |
|
Quantitative Units |
Representation of revenue in US$ Bn and CAGR from 2025 to 2034 |
|
Historic Year |
2021 to 2024 |
|
Forecast Year |
2025-2034 |
|
Report Coverage |
The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
|
Segments Covered |
By End-Users |
|
Regional Scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
|
Country Scope |
U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; France; Italy; Spain; South Korea; South East Asia |
|
Competitive Landscape |
PerkinElmer, Inc., Merck KGaA, Sartorius AG, Thermo Fisher Scientific, Inc., Carl Zeiss Meditec AG, Charles River Laboratories, Yokogawa Electric Corporation, and Nanolive SA. |
|
Customization Scope |
Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape. |
|
Pricing And Available Payment Methods |
Explore pricing alternatives that are customized to your particular study requirements. |
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Image Based Cytometry in Cell Analysis Market Snapshot
Chapter 4. Global Image Based Cytometry in Cell Analysis Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter’s Five Forces Analysis
4.7. COVID-19 Impact Analysis
Chapter 5. Market Segmentation 1: By End-user Estimates & Trend Analysis
5.1. By End-user & Market Share, 2024-2034
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By End-user:
5.2.1. Biotechnology & Pharmaceutical Companies
5.2.2. Therapeutic Area
5.2.2.1. Oncology & Immune oncology
5.2.2.2. Cardiovascular & Metabolic Diseases
5.2.2.3. Immunology
5.2.2.4. Rare Diseases
5.2.2.5. Neurological Diseases
5.2.2.6. Others
5.2.3. Workplace
5.2.3.1. Target Identification
5.2.3.2. Hit Generation & Lead Identification
5.2.3.3. Lead Optimization
5.2.3.4. In Vitro Preclinical Studies
5.2.3.5. In Vivo Preclinical Studies
5.2.3.6. Clinical Studies
5.2.4. Academia
5.2.5. Cosmetic Industry
5.2.6. Contract Research Organizations
5.2.7. Contract Development & Manufacturing Organizations
Chapter 6. Image Based Cytometry in Cell Analysis Market Segmentation 2: Regional Estimates & Trend Analysis
6.1. North America
6.1.1. North America Image Based Cytometry in Cell Analysis Market revenue (US$ Million) estimates and forecasts By End-user, 2021-2034
6.1.2. North America Image Based Cytometry in Cell Analysis Market revenue (US$ Million) estimates and forecasts by country, 2021-2034
6.1.2.1. U.S.
6.1.2.2. Canada
6.2. Europe
6.2.1. Europe Image Based Cytometry in Cell Analysis Market revenue (US$ Million) By End-user, 2021-2034
6.2.2. Europe Image Based Cytometry in Cell Analysis Market revenue (US$ Million) By country, 2021-2034
6.2.2.1. Germany
6.2.2.2. Poland
6.2.2.3. France
6.2.2.4. Italy
6.2.2.5. Spain
6.2.2.6. UK
6.2.2.7. Rest of Europe
6.3. Asia Pacific
6.3.1. Asia Pacific Image Based Cytometry in Cell Analysis Market revenue (US$ Million) By End-user, 2021-2034
6.3.2. Asia Pacific Image Based Cytometry in Cell Analysis Market revenue (US$ Million) By country, 2021-2034
6.3.2.1. China
6.3.2.2. India
6.3.2.3. Japan
6.3.2.4. Australia
6.3.2.5. Rest of Asia Pacific
6.4. Latin America
6.4.1. Latin America Image Based Cytometry in Cell Analysis Market revenue (US$ Million) By End-user, 2021-2034
6.4.2. Latin America Image Based Cytometry in Cell Analysis Market revenue (US$ Million) By country, (US$ Million) 2021-2034
6.4.2.1. Brazil
6.4.2.2. Rest of Latin America
6.5. Middle East & Africa
6.5.1. Middle East & Africa Image Based Cytometry in Cell Analysis Market revenue (US$ Million) By End-user, (US$ Million)
6.5.2. Middle East & Africa Image Based Cytometry in Cell Analysis Market revenue (US$ Million) By country, (US$ Million) 2021-2034
6.5.2.1. South Africa
6.5.2.2. GCC Countries
6.5.2.3. Rest of MEA
Chapter 7. Competitive Landscape
7.1. Major Mergers and Acquisitions/Strategic Alliances
7.2. Company Profiles
7.2.1. PerkinElmer, Inc.
7.2.2. Merck KGaA
7.2.3. Sartorius AG
7.2.4. Thermo Fisher Scientific, Inc.
7.2.5. Carl Zeiss Meditec AG
7.2.6. Charles River Laboratories
7.2.7. Yokogawa Electric Corporation
7.2.8. Nanolive SA
Image-Based Cytometry in Cell Analysis Market By End User-
By Region-
North America-
Europe-
Asia-Pacific-
Latin America-
Middle East & Africa-
InsightAce Analytic follows a standard and comprehensive market research methodology focused on offering the most accurate and precise market insights. The methods followed for all our market research studies include three significant steps – primary research, secondary research, and data modeling and analysis - to derive the current market size and forecast it over the forecast period. In this study, these three steps were used iteratively to generate valid data points (minimum deviation), which were cross-validated through multiple approaches mentioned below in the data modeling section.
Through secondary research methods, information on the market under study, its peer, and the parent market was collected. This information was then entered into data models. The resulted data points and insights were then validated by primary participants.
Based on additional insights from these primary participants, more directional efforts were put into doing secondary research and optimize data models. This process was repeated till all data models used in the study produced similar results (with minimum deviation). This way, this iterative process was able to generate the most accurate market numbers and qualitative insights.
Secondary research
The secondary research sources that are typically mentioned to include, but are not limited to:
The paid sources for secondary research like Factiva, OneSource, Hoovers, and Statista
Primary Research:
Primary research involves telephonic interviews, e-mail interactions, as well as face-to-face interviews for each market, category, segment, and subsegment across geographies
The contributors who typically take part in such a course include, but are not limited to:
Data Modeling and Analysis:
In the iterative process (mentioned above), data models received inputs from primary as well as secondary sources. But analysts working on these models were the key. They used their extensive knowledge and experience about industry and topic to make changes and fine-tuning these models as per the product/service under study.
The standard data models used while studying this market were the top-down and bottom-up approaches and the company shares analysis model. However, other methods were also used along with these – which were specific to the industry and product/service under study.
To know more about the research methodology used for this study, kindly contact us/click here.
